TheLancet

95 Voos
TheLancet

TheLancet

Espelho

@TheLancet

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.

Se esta é sua conta, você pode reivindicar este perfil.

thelancet.comIngressou em março de 2026
Treatment options for those with haemophilia has steadily improved, with the introduction of gene therapy presenting as the next big step forward. A new Viewpoint examines the ethical and practical safeguards required to ensure the safe and equitable implementation of gene ther…
Hereditary haemolytic anaemias represent the most prevalent group of genetic disorders worldwide. A Therapeutics paper provides a comprehensive overview of pyruvate kinase activators as a novel therapeutic approach for hereditary haemolytic anaemias: spkl.io/6019AFnYF
Retroperitoneal fibrosis is a rare immune-mediated disease which can be classified as idiopathic or secondary. A new Seminar provides an overview of retroperitoneal fibrosis focusing on pathophysiology, differential diagnosis, and management: spkl.io/6010AFXEE
Africa produces less than 5% of the diagnostics and just 1% of the vaccines it uses — a dependency that weakens emergency response, increases costs, and puts lives at risk. In our latest Correspondence in @TheLancet, co-authored with my colleagues at @AfricaCDC, we highlight the
🎙️ New Lancet Pulse – Prof Tien Yin Wong discusses Tsinghua’s world-first AI hospital project. Learn about the promise and reality checks of AI in healthcare, plus China’s broader health challenges. spkl.io/6015AFwRL
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney disease. A Review focuses on current approaches to diagnosis, treatment, and specific aspects of clinical management. Read more: spkl.io/6013AF8kV
Sepsis is a serious condition where the body’s response to an infection becomes out of control and starts to damage its own organs. A Seminar explores the complexity of the condition, and discusses current challenges and future developments in care: spkl.io/6011AFBJ3
Primary sclerosing cholangitis is a rare liver disease, characterised by biliary inflammation and fibrosis. A new Seminar explores the clinical features, pathogenesis, and challenges and opportunities in managing the disease: spkl.io/6017A0073
📣 Join our Lancet Webinar! Join our expert editors as they guide you through the different pathways to publication for diabetes content across The Lancet Group and answer your questions about submitting your work to us. Register now: hubs.li/Q046TzZF0
Increased fluid intake is universally recommended to decrease the risk of recurrent urinary stones; yet, adherence is challenging. 🆕 A study investigated whether a behavioural intervention programme to promote high fluid intake reduces stone recurrence: spkl.io/6011A0P9b
GLP-1 receptor agonists have revolutionised obesity management. Yet high costs, limited production capacity, and supply-chain constraints have resulted in persistent inequitable access. This could be about to change. Find out more in our new issue: spkl.io/6014ALFHr
Sepsis is a serious condition where the body’s response to an infection becomes out of control and starts to damage its own organs. A Seminar explores the complexity of the condition, and discusses current challenges and future developments in care: spkl.io/6015ALnw1
Hereditary haemolytic anaemias represent the most prevalent group of genetic disorders worldwide. A new Therapeutics paper provides a comprehensive overview of pyruvate kinase activators as a novel therapeutic approach for hereditary haemolytic anaemias: spkl.io/6010ALnP8
📢 Have you reserved your space? Join Pierre Nauleau for a Lancet Webinar exploring our new journal – The Lancet Medical Imaging & Theranostics. Get practical tips on how to optimise your manuscript for success. 👉 Register: hubs.li/Q044__qT0
“Cancer world is an isolating place. For those of us who negotiate it while pregnant, the difficulties we encounter compound this feeling.” Na'ama Carlin on cancer in pregnancy: navigating two medical systems spkl.io/6014ALGLA
Glaucoma is a leading cause of irreversible blindness worldwide and often goes undiagnosed until vision loss is advanced. A new AI-based screening tool reduces the number of unnecessary referrals for glaucoma by half, according to a new study ▶️ spkl.io/6012AItOM
Sickle cell disease is one of the most prevalent and fastest-growing genetic disorders, affecting nearly 8 million people worldwide. However, current global standards of care are not aligned with the scale and severity of the disease. Read more in our Editorial▶️ t.co/KQtfAQUuGZ
On the cover of The Lancet: a call to enhance civilian and military blood preparedness. With global demand already exceeding supply, establishing a clear preparedness timeline is vital. Read more in our latest issue ▶️ spkl.io/6011AIUMB